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During fasting and after exercise, skeletal muscle
efficiently switches from carbohydrate to lipid as
the main energy source to preserve glycogen stores
and blood glucose levels for glucose-dependent
tissues. Skeletal muscle cells sense this limitation
in glucose availability and transform this information
into transcriptional and metabolic adaptations. Here
we demonstrate that AMPK acts as the prime initial
sensor that translates this information into SIRT1-
dependent deacetylation of the transcriptional regu-
lators PGC-1a and FOXO1, culminating in the tran-
scriptional modulation of mitochondrial and lipid
utilization genes. Deficient AMPK activity compro-
mises SIRT1-dependent responses to exercise and
fasting, resulting in impaired PGC-1a deacetylation
and blunted induction of mitochondrial gene expres-
sion. Thus, we conclude that AMPK acts as the
primordial trigger for fasting- and exercise-induced
adaptations in skeletal muscle and that activation
of SIRT1 and its downstream signaling pathways
are improperly triggered in AMPK-deficient states.
INTRODUCTION
During fasting or energy deficits, the limiting glucose availability
must be compensated by an increase in mitochondrial fatty acid
oxidation in skeletal muscle and other peripheral tissues to
preserve blood glucose levels and supply glucose-dependent
tissues, such as the brain or red blood cells (Cahill et al., 1966).
The lack of metabolic flexibility to correctly adapt to energy
demands and nutrient availability constitutes a burden on energy
homeostasis, ultimately leading to metabolic disease (Kelley and
Mandarino, 2000). Metabolic adaptations in muscle are driven by
coordinated transcriptional responses to promote the mitochon-
drial use of lipid substrates as a source of energy (de Lange et al.,
2006). Such alterations in gene expression patterns are achieved
through the modulation of transcriptional regulators, such as the
coactivator PGC-1a or the FOXO family of transcription factors,
both of which are intimately linked to the regulation of mitochon-
drial and fatty acid metabolism (Gross et al., 2008; HandschinCeand Spiegelman, 2006). The activities of PGC-1a (Rodgers
et al., 2005) and FOXOs (Brunet et al., 2004) are critically influ-
enced by the control of their acetylation levels through the type
III NAD+-dependent deacetylase SIRT1. As a result, SIRT1 acts
as master regulator of muscle adaptations to nutrient availability
(Fulco et al., 2008; Gerhart-Hines et al., 2007). Notably, SIRT1
knockdown prevents the induction of mitochondrial and lipid
oxidation genes in glucose-restricted myotubes (Gerhart-Hines
et al., 2007). How SIRT1 activity is regulated is still largely
unknown, even thought it has been hypothesized that NAD+
availability, for which SIRT1 acts as a sensor, plays a major
role (Gerhart-Hines et al., 2007).
Another metabolic sensor with strong impact on transcrip-
tional responses is the AMP-activated protein kinase (AMPK),
a heterotrimeric Ser/Thr kinase composed of one catalytic (a)
and two noncatalytic subunits (b and g) (Hardie, 2007). Two
different isoforms exist for both the a and the b subunits (a1
and a2 or b1 and b2), while the g subunits are encoded by three
different genes (g1, g2, and g3) (Hardie, 2007). The g subunits
can bind AMP or ATP in a competitive and mutually exclusive
manner (Hardie, 2007). The binding of AMP increases the cata-
lytic activity of the complex and enhances the phosphorylation
of a key residue within the catalytic domain (Thr172), essential
for activity. In contrast, the binding of ATP antagonizes the
effects of AMP on enzymatic activity, transforming AMPK into
an energy-monitoring system of AMP:ATP ratio. The activation
of AMPK turns on catabolic pathways to generate ATP, and
switches off a number of processes that consume ATP, such
as fatty acid, protein, or cholesterol synthesis (Hardie, 2007).
Interestingly, the activity of AMPK seems connected to that of
SIRT1. AMPK enhances SIRT1 activity by increasing intracellular
NAD+ levels (Canto et al., 2009; Costford et al., 2009; Fulco et al.,
2008). This translates in the deacetylation of SIRT1 targets, such
as PGC-1a, in response to pharmacological or physiological
AMPK activation (Canto et al., 2009). Whether AMPK is required
for fasting-induced activation of SIRT1 and deacetylation of its
targets remains unknown. Here we provide evidence that
AMPK acts as the primordial sensor of energy stress and that
its activity is required to trigger SIRT1-dependent adaptations.
RESULTS
C2C12 myotubes display a number of adaptive changes after
48 hr incubation in glucose-restricted medium (5 mM). Forll Metabolism 11, 213–219, March 3, 2010 ª2010 Elsevier Inc. 213
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Figure 1. Glucose Restriction Increases PGC-1a-Dependent Gene Expression
(A–C) C2C12 myotubes were infected with adenoviruses encoding FLAG-HA-PGC-1a. Then, cells were left for 48 hr in medium containing either 25 mM glucose
(HG) or 5 mM glucose (LG). A third group was treated by adding 25 mM glucose medium for 6 hr after 48 hr in LG (LG + 6 hr HG). (A) Total protein was obtained and
100 mg were used for western blot analysis to test the markers indicated. (B) Of total protein extracts, 500 mg was used for immunoprecipitation (IP) against FLAG
antibody or against FOXO to determine the acetylation levels of PGC-1a or FOXO1, respectively. (C) Acidic lysates were obtained for measurement of NAD+
levels. Data are presented as mean ± SE from 6 different experiments. * indicates statistical difference versus HG group.
(D) Nuclear extracts (300 mg) from gastrocnemius muscle from fed, fasted, or refed C57BL/6J mice were used for IP against PGC-1a or FOXO1 to measure
acetylation.
(E–G) After infection with adenoviruses encoding FLAG-HA-PGC-1a, C2C12 myotubes were left in 5 mM glucose medium and samples were obtained at the
times indicated. (E) Of total protein extracts, 100 mg was used for western analysis to test the markers indicated. (F) Of total protein extracts, 500 mg was
used for immunoprecipitation to detect the acetylation levels of PGC-1a. (G) Acidic lysates were obtained for measurement of NAD+ levels. Data are presented
as mean ± SE from five different experiments. * indicates statistical difference versus t = 0. All images are representative of three to six independent experiments.
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AMPK Governs SIRT1/PGC-1a-Dependent Adaptationsexample, AMPK is activated, as manifested by the phosphoryla-
tion on the Thr172 residue of the a subunit and the phosphoryla-
tion of ACC, an AMPK substrate (Figure 1A). This was in parallel
to the downregulation of the mTOR pathway, as evidenced by
p70S6K phosphorylation (Figure 1A), and the deacetylation of
SIRT1 targets, PGC-1a and FOXO1 (Figure 1B). The deacetyla-
tion of SIRT1 targets was not due to higher SIRT1 protein levels
(Figure 1A) but rather due to changes in activity derived from
increased NAD+ levels (Figure 1C), which reflected a metabolic
rearrangement toward oxidative metabolism. Consequent to
the changes in PGC-1a and FOXO activity through deacetyla-
tion, the expression of mitochondrial and lipid oxidation genes
was increased after 48 hr in low-glucose medium (see
Figure S1 available online). The deacetylation of these transcrip-
tional regulators could also be observed in mouse gastrocne-
mius muscle after overnight fasting (Figure 1D). Remarkably,
these changes were rapidly reversed by reincubating myotubes
in 25 mM glucose or refeeding mice (Figures 1A–1D and
Figure S1). Hence, the activity of metabolic sensors and the
acetylation levels and activity of SIRT1 targets coordinately
respond to external nutrient availability.
We then explored the sequential events leading to the adapta-
tions in glucose restriction. AMPK and ACC phosphorylation
increased 18–24 hr after incubation in low glucose, in parallel
to a decrease in mTOR signaling (Figure 1E). Changes in
PGC-1a acetylation levels took place 30–36 hr after incubation214 Cell Metabolism 11, 213–219, March 3, 2010 ª2010 Elsevier Inc.in low-glucose medium (Figure 1B), in the absence of changes
in SIRT1 protein levels (Figure 1E). Intracellular NAD+ levels
increased 30–36 hr after glucose restriction, in line with the
timing for PGC-1a deacetylation (Figure 1F). These results indi-
cate that changes in AMPK activity during glucose restriction
precede changes in NAD+ levels and SIRT1 activity.
Based on the above results, we tested whether AMPK could
act as the primordial sensor triggering SIRT1-dependent
metabolic adaptations. For this purpose, we overexpressed
lacZ (control), wild-type (WT), or dominant-negative (DN) forms
of AMPKa1 and examined the activation of PGC-1a in re-
sponse to glucose deprivation. The DN-AMPKa1 robustly pre-
vented AMPK activity (Figure 2A) and impaired PGC-1a deace-
tylation upon glucose restriction (Figure 2B). Consistent with
the impaired deacetylation, studies on the mouse PGC-1a
promoter reporter, which itself is activated in a PGC-1a-
dependent manner, revealed that PGC-1a transcriptional
activity was not significantly enhanced in glucose-restricted
cells when AMPK activity was blunted (Figure 2C). Interest-
ingly, DN-AMPKa1 did not prevent the transcriptional activity
of a PGC-1a mutant where the 13 acetylable lysines are
mutated to arginine (R13) (Figure 2C). This latter observation
suggests that the phosphorylation of PGC-1a by AMPK (Jager
et al., 2007) might act as a signal for deacetylation but does
not contribute to the intrinsic activity of this transcriptional
cofactor.
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Figure 2. Disruption of AMPK Activity Renders PGC-1a Activity and Metabolic Adaptations Unresponsive to Glucose Restriction
(A) C2C12 myotubes were infected with adenovirus encoding FLAG-HA-PGC-1a and either lacZ, a WT, or a DN form of AMPKa1. After infection, cells were left for
48 hr in 25 or 5 mM glucose medium. Of total extracts, 100 mg was used for western analysis.
(B) As in (A), but 500 mg from total extracts were used for immunoprecipitation against FLAG to test PGC-1a acetylation levels.
(C) C2C12 myoblasts were transfected with lacZ and either an empty vector (data not shown) or a luciferase reporter construct linked to the mouse PGC-1a
promoter. Simultaneously, cells were infected with adenovirus encoding for GFP (), FLAG-HA-PGC-1a, FLAG-HA-PGC-1a R13, WT-AMPKa1, or DN-AMPKa1
as indicated. Thirty-six hours later, cells were incubated for 48 hr in medium containing either 25 or 5 mM glucose, and luciferase activity was measured. A repre-
sentative assay of four independent experiments is shown. Values are expressed as mean ± SE. * indicates statistical difference versus corresponding 25 mM
glucose group.
(D) Similar to (A), but total mRNA was obtained for qRT-PCR analysis. Relative mRNA levels are shown as mean ± SE from four experiments. * indicates statistical
difference versus corresponding 25mM glucose group. # indicates statistical difference versus lacZ-infected 25 mM group.
(E) C2C12 myotubes were infected as in (A). Then cells were left in 25 or 5 mM glucose medium. At the indicated time points, O2 consumption, oleate, and glucose
oxidation rates were measured. Results are shown as mean ± SE from 12, 6, and 4 independent experiments, respectively. * indicates statistical difference versus
time = 0 hr.
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AMPK Governs SIRT1/PGC-1a-Dependent AdaptationsIn line with the defective PGC-1a activation during glucose
restriction, the DN-AMPKa1 prevented the increase in the
mRNA levels of mitochondrial and fatty acid oxidation genes,
such as PPARa, CPT-1b, mitofusin-2 (Figure 2D), ERRa, PDK4,
and COXIV (Figure S2). We next evaluated the physiological
impact of these changes by analyzing how oxidative metabolism
responded to glucose restriction when AMPK activation is
impaired. O2 consumption gradually increased 24 and 48 hr after
glucose restriction in lacZ- and WT-AMPKa1-expressing myo-
tubes (Figure 2E). This response was largely attenuated in cells
expressing DN-AMPKa1 (Figure 2E). While total O2 consumption
in lacZ- and WT-AMPKa1-expressing myotubes increased
50.9% ± 9.7% and 45.5% ± 9.9%, respectively, after 48 hr in
LG medium, only a 25.1% ± 5.7% increase was detected in
the presence of DN-AMPKa1 (Figure 2E). These differences
were more evident when lipid oxidation was specifically exam-
ined. Even 48 hr after the initiation of glucose restriction, fatty
acid oxidation rates were unaltered in myotubes expressing
DN-AMPKa1, in sharp contrast with myotubes expressing either
lacZ or WT-AMPKa1 (Figure 2E). Furthermore, impaired AMPK
activation prevented the decrease in glucose oxidation rates
observed in lacZ- and WT-AMPKa1-expressing myotubesCe(Figure 2E). Hence, AMPK activation during energy stress
allows a rapid shift from glucose to lipid as the main substrate
for oxidation.
To provide in vivo evidence to support the above results, we
used mice deficient in the AMPKg3 subunit (Barnes et al.,
2004) The g3 is the predominant g-isoform in glycolytic skeletal
muscle (Mahlapuu et al., 2004) and is critical for effective adap-
tations of glycolytic muscle to metabolic challenges (Barnes
et al., 2005b; Long et al., 2005). Fasting-induced PGC-1a and
FOXO1 deacetylation was evident in EDL muscles from WT
mice but severely blunted in AMPKg3 KO mice (Figure 3A).
This defective SIRT1 activity could be consequent to the fact
that intramuscular levels of NAD+ were unresponsive to fasting
in AMPKg3 KO mice (Figure 3B). Notably, muscle glycogen levels
in WT mice dropped 35% (5 mmols 3 kg1) after fasting,
while 55% (7 mmols 3 kg1) in the AMPKg3 KOs
(Figure 3C), suggesting that the AMPKg3 KOs cannot shift to
noncarbohydrate energy sources as efficiently as their WT litter-
mates. Consequent to reduced PGC-1a activation, the expres-
sion of PGC-1a target genes was also impaired upon fasting in
AMPKg3 KO mice (Figure 3D). Interestingly, fasting induced
Nampt expression, but this increase was blunted in the AMPKg3ll Metabolism 11, 213–219, March 3, 2010 ª2010 Elsevier Inc. 215
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Figure 3. Impaired PGC-1a Deacetylation
and Transcriptional Response to Fasting in
AMPKg3 Kos
WT and AMPKg3 KO mice in fed or fasted (20 hr)
state were sacrificed, and muscles were extracted
and frozen.
(A) Of total protein extracts from EDL muscles,
2 mg was used to immunoprecipitate FOXO1 and
PGC-1a and check their acetylation. Relative
quantifications of FOXO1 and PGC-1a acetylation
levels are shown on the right as mean ± SE of six
muscles/group.
(B) Acidic extracts from 50 mg of gastrocnemius
muscle were used to measure NAD+ content.
Results are shown as mean ± SE from six muscles
measured in duplicate.
(C) Quadriceps muscle (20 mg) was used to
measure glycogen content. Results are shown as
mean ± SE from five muscles. # indicates statis-
tical difference between the groups indicated.
(D) Total mRNA was extracted from quadriceps
muscles and used for qPCR analysis. Results are
shown as mean ± SE from ten muscles/group.
Through the figure, * indicates statistical difference
versus respective fed group.
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AMPK Governs SIRT1/PGC-1a-Dependent AdaptationsKOs (Figure 3D), providing an additional explanation for the lack
of changes in NAD+ levels. Next, we tested whether administra-
tion of a claimed SIRT1 activator, such as resveratrol (Rsv), could
rescue the defective response of PGC-1a acetylation to fasting
in the EDL muscles of AMPKg3 KOs. Interestingly, Rsv efficiently
decreased PGC-1a acetylation levels in EDL muscles from WT
mice (Figure S3) but was unable to do so in muscles from the
AMPKg3 KOs (Figure S3), indicating that the actions of Rsv on
PGC-1a deacetylation require intact AMPK activity.
Finally, we evaluated whether AMPK was required for PGC-1a
deacetylation in response to exercise, the most common energy
challenge in skeletal muscle. PGC-1a and FOXO1 were robustly
deacetylated 2.5 hr after swimming, an effect that was partially
blunted in the AMPKg3 KO mice (Figure 4A). As observed in
fasted muscle, the increase in NAD+ observed during exercise
recovery in WT mice was absent in AMPKg3 KOs (Figure 4B). A
recent report indicated that increases in NAD+ and SIRT1 activity
after exercise could also derive from an increase in Nampt (Cost-
ford et al., 2009). Noteworthily, Nampt induction after exercise
was impaired in AMPKg3 KO mice (Figure 4C), further indicating
that AMPK controls Nampt expression (Figure 4C). Also similar
to what was observed in fasting, glycogen levels were markedly
lower in the AMPKg3 KO mice 2.5 hr after exercise (Figure 4D).
This is in line with previous findings (Mu et al., 2003), indicating
an impaired ability to rely on fat oxidation to recover glycogen
levels.
DISCUSSION
We report that the acetylation levels of two SIRT1 targets, the
transcriptional regulators PGC-1a and FOXO1, dynamically
respond to energy stresses, such as exercise and fasting in skel-
etal muscle, or changes in glucose availability in C2C12 myo-
tubes. Furthermore, our results indicate that AMPK activation
precedes and determines the changes in SIRT1 activity
in situations of energy stress. The regulation of the acetylation216 Cell Metabolism 11, 213–219, March 3, 2010 ª2010 Elsevier Inc.levels of transcriptional regulators through the AMPK/SIRT1
axis provides a mechanism by which mitochondrial and lipid
oxidation genes can be rapidly and selectively controlled in
response to energy levels.
Genetic ablation of the AMPKg3 subunit largely prevents phys-
iological and/or pharmacological activation of AMPK (Barnes
et al., 2005a) and was enough to impair fasting- and exercise-
induced PGC-1a deacetylation. This unequivocally proves that
SIRT1-mediated deacetylation of PGC-1a requires functional
AMPK. The unchanged NAD+ levels after fasting or during exer-
cise recovery in the AMPKg3 KO mice suggest that these mice
are metabolically inflexible and, together with the defective
induction of Nampt, might explain the defective SIRT1 activation.
Along the same line, the AMPKg3 KO mice showed higher
glycogen depletion on fasting and after exercise. Our results
reinforce previous observations showing that AMPK-defective
mice have impaired glycogen metabolism (Barnes et al., 2005a;
Fujii et al., 2007; Mu et al., 2003). Additionally, AMPKg3 KO mice
highly rely on glucose metabolism during exercise recovery
(Barnes et al., 2005a), explaining why glycogen levels hardly
recover after exercise. Similarly, myotubes expressing a
DN-AMPKa1 highly depend on glucose as oxidative energy
source even during glucose restriction. Altogether, these data
illustrate that AMPK is necessary to efficiently shift between
different energy substrates in the muscle and optimize the use
of glycogen stores.
Noteworthily, while several models of AMPK deficiency
display decreased basal mitochondrial gene expression (Jor-
gensen et al., 2005), lower voluntary exercise activity (Mu
et al., 2001), and lower exercise tolerance (Fujii et al., 2007),
defective AMPK does not robustly affect exercise-induced
gene expression (Barnes et al., 2005b; Jorgensen et al., 2005).
In line with this, AMPK acts on mitochondrial gene expression
through PGC-1a (Jager et al., 2007), which itself is dispensable
for mitochondrial gene induction after exercise (Leick et al.,
2008). Contrastingly, AMPK is required for mitochondrial
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Figure 4. Impaired PGC-1a Deacetylation in Response to Exercise in AMPKg3 Kos
(A) WT and AMPKg3 KO mice were sacrificed at rest or 2.5 hr after swimming (see the Experimental Procedures), and muscles were frozen. Nuclear extracts
(300 mg) from gastrocnemius or 2 mg of total proteins from EDL muscles were used to immunoprecipitate PGC-1a and check its acetylation levels. Quantifications
of PGC-1a acetylation levels are shown on the right as mean ± SE.
(B) Acidic extracts from 50 mg of gastrocnemius were used to measure NAD+. Results are shown as mean ± SE from three to four muscles per group measured in
duplicate.
(C) Total mRNA from quadriceps was used to measure Nampt expression.
(D) Quadriceps muscle (20 mg) was used to measure glycogen content. Results are shown as mean ± SE from three to four muscles per group measured in dupli-
cate. # indicates statistical difference between the groups indicated.
(E) Proposed scheme for the coordinated regulation of lipid utilization during energy stress. Upon low nutrient availability or increased energy demand, as during
exercise, there is an increase in the AMP/ATP ratio, which activates AMPK, enhancing lipid oxidation in the mitochondria and inducing Nampt levels. These events
will raise intracellular NAD+ levels, triggering SIRT1 activation, which deacetylates PGC-1a and FOXOs, both of which regulate genes that further favor mitochon-
drial respiration and lipid mobilization. Through the figure, * indicates statistical difference versus respective fed group.
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AMPK Governs SIRT1/PGC-1a-Dependent Adaptationsbiogenesis upon pharmacological energy depletion (Zong et al.,
2002). This reflects how exercise triggers more pathways than
those derived from energy depletion, which redundantly regulate
exercise-induced transcriptional changes (Jensen et al., 2009).
The clear effect of the ablation of AMPKg3 on fasting-induced
PGC-1a responses is striking, as AMPK activation during fasting
is controversial (de Lange et al., 2006). AMPK activity, however,
was estimated to be50% lower in the AMPKg3 KOs than in WT
mice after fasting (Barnes et al., 2005a). An additional explana-
tion for the defects observed lies in the fact that NAD+ levels
remain stable during fasting/feeding transitions in the AMPKg3
KO mice, probably due to the inability of their mitochondria to
shift between substrates (Barnes et al., 2005a), which would
prevent activation of SIRT1. This link between AMPK and mito-
chondrial fitness might also explain why AMPK participates in
the adaptations to other situations such as calorie restriction
(Apfeld et al., 2004; Schulz et al., 2007).
From a pharmacological perspective, our results on incubated
muscle show that Rsv, initially believed to be a direct SIRT1 acti-
vator, requires AMPK to promote PGC-1a deacetylation in
glycolytic muscle. Together with recent data (Um et al., 2009),
our results suggest that SIRT1 activation in response to Rsv,
rather than being a direct effect on SIRT1, might be an indirect
consequence of AMPK activation (Canto et al., 2009). AnotherCeexplanation is that phosphorylation by AMPK might be required
for PGC-1a deacetylation by SIRT1 (Canto et al., 2009). Conse-
quently, PGC-1awould remain acetylated when AMPK activity is
defective even when SIRT1 is active. Altogether, these observa-
tions indicate that Rsv requires AMPK for its metabolic effects.
Based on our data, we propose that AMPK acts as an initial
sensor of energy stress and allows the cell to efficiently shift
between different energetic substrates. This, together with the
ability of AMPK to regulate Nampt expression, impacts on intra-
cellular NAD+ levels, which modulate SIRT1 action on its down-
stream targets such as PGC-1a and FOXO1 (Figure 4D). Conse-
quently, SIRT1 activation constitutes an indirect consequence of
the metabolic and transcriptional rearrangements induced by
AMPK activation.
EXPERIMENTAL PROCEDURES
Reagents and Materials
A full list of reagents and materials is provided in the Supplemental Experi-
mental Procedures.
Animal Studies
For the fasting experiment in Figure 1, animals were purchased from Charles
River (L’Arbresle, France). Ten-week-old C57Bl/6J male mice were maintained
in a temperature-controlled (23C) facility with a 12 hr light/dark cycle. To studyll Metabolism 11, 213–219, March 3, 2010 ª2010 Elsevier Inc. 217
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AMPK Governs SIRT1/PGC-1a-Dependent Adaptationsthe effects of fasting, food was removed for 16 hr, including the overnight
period. The AMPKg3 KO mice have been described previously (Barnes
et al., 2004). WT or AMPKg3 KO mice (6–9 months old) had free access to
water and standard rodent chow. When examining the effects of fasting,
food was removed 20 hr prior to the extraction of hindlimb muscles, which
were cleaned of fat and blood and quickly frozen in liquid nitrogen. For exercise
experiments, mice swam in 45cm Ø plastic containers for four 30 min intervals
separated by 5 min rest periods for a total swimming time of 2 hr. Then mice
were dried and allowed to recover from exercise for 2.5 hr. In the recovery
period mice had free access to food and water.Cell Culture and Adenoviral Infection
C2C12 skeletal muscle cells were grown and differentiated as described
(Canto et al., 2009). C2C12 were considered as myotubes after 96 hr of differ-
entiation. Differentiation medium was supplemented with BSA-conjugated
oleic acid (0.2 mM). Adenoviral infections of C2C12 myocytes were performed
after 48 hr of differentiation. Cells were washed with PBS and left for 1 hr in
serum-free DMEM 4.5g/l glucose containing the appropriate amount of viral
particles (moi = 100 per each virus used, using GFP (for the different
PGC-1a forms) or lacZ (for AMPKa1 WT and DN forms) as control to make
even the final viral amount). Media was replaced with fresh differentiation
media for an additional 48 hr before any treatment took place. All the adeno-
viruses used in this study have been described (Rodgers et al., 2005; Woods
et al., 2000).Metabolic Measurements
Oxygen consumption was measured using the XF24 equipment (Seahorse
Bioscience Inc., North Billerica, MA) as described (Watanabe et al., 2006).
Oleate and glucose oxidation rates were estimated as described previously
(Pich et al., 2005).NAD+ and NADH Measurements
NAD+ intracellular levels in muscle (50 mg) and cultured myotube samples
(1 mg) were estimated as described (Rodgers et al., 2005).Statistics
Differences between two groups were assessed using two-tailed t tests. Anal-
ysis of variance, assessed by Bonferroni’s multiple comparison test, was used
when comparing more than two groups.
Additional experimental procedures can be found in the Supplemental
Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
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